Corporate communications? Dammed if you do dammed if you don't. Nanoviricides is propelled by science (with vision and hope sprinkled to taste). PR costs money. I prefer my share of this investment dedicated to the science not to placating the market and those too impatient for long term, speculative investing. BioPharm is not for the faint of heart or those who might need returns to support current expenses.